Related references
Note: Only part of the references are listed.JMJD6 and U2AF65 co-regulate alternative splicing in both JMJD6 enzymatic activity dependent and independent manner
Jia Yi et al.
NUCLEIC ACIDS RESEARCH (2017)
Structure, biochemistry, and biology of PAK kinases
Rakesh Kumar et al.
GENE (2017)
The role of RNA alternative splicing in regulating cancer metabolism
Itamar Kozlovski et al.
HUMAN GENETICS (2017)
Oncometabolite succinate promotes angiogenesis by upregulating VEGF expression through GPR91-mediated STAT3 and ERK activation
Xianmin Mu et al.
ONCOTARGET (2017)
CSE1L Links cAMP/PKA and Ras/ERK Pathways and Regulates the Expressions and Phosphorylations of ERK1/2, CREB, and MITF in Melanoma Cells
Woan-Ruoh Lee et al.
MOLECULAR CARCINOGENESIS (2016)
BRAF and Epithelial-Mesenchymal Transition: Lessons From Papillary Thyroid Carcinoma and Primary Cutaneous Melanoma
Brendon Mitchell et al.
ADVANCES IN ANATOMIC PATHOLOGY (2016)
Mitogen-Activated Protein Kinase Signaling Pathway in Cutaneous Melanoma
Andres Martin Acosta et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2016)
Notch1-MAPK Signaling Axis Regulates CD133+ Cancer Stem Cell-Mediated Melanoma Growth and Angiogenesis
Dhiraj Kumar et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2016)
PCAF-mediated acetylation of transcriptional factor HOXB9 suppresses lung adenocarcinoma progression by targeting oncogenic protein JMJD6
Junhu Wan et al.
NUCLEIC ACIDS RESEARCH (2016)
C-reactive protein can upregulate VEGF expression to promote ADSC-induced angiogenesis by activating HIF-1α via CD64/PI3k/Akt and MAPK/ERK signaling pathways
JiaYuan Chen et al.
STEM CELL RESEARCH & THERAPY (2016)
The epigenetic modifier JMJD6 is amplified in mammary tumors and cooperates with c-Myc to enhance cellular transformation, tumor progression, and metastasis
Olga Aprelikova et al.
CLINICAL EPIGENETICS (2016)
In vivo gene manipulation reveals the impact of stress-responsive MAPK pathways on tumor progression
Miki Kamiyama et al.
CANCER SCIENCE (2015)
p38 and JNK MAPK pathways control the balance of apoptosis and autophagy in response to chemotherapeutic agents
Xinbing Sui et al.
CANCER LETTERS (2014)
Molecular mechanisms of epithelial-mesenchymal transition
Samy Lamouille et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
JMJD6 Promotes Colon Carcinogenesis through Negative Regulation of p53 by Hydroxylation
Feng Wang et al.
PLOS BIOLOGY (2014)
A melanocyte lineage program confers resistance to MAP kinase pathway inhibition
Cory M. Johannessen et al.
NATURE (2013)
High expression of JMJD6 predicts unfavorable survival in lung adenocarcinoma
Ji Zhang et al.
TUMOR BIOLOGY (2013)
BRCA1 exon 11 alternative splicing, multiple functions and the association with cancer
Claudia Tammaro et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2012)
Tailoring of Membrane Proteins by Alternative Splicing of Pre-mRNA
Kathleen F. Mittendorf et al.
BIOCHEMISTRY (2012)
Therapy for metastatic melanoma: the past, present, and future
Laura Finn et al.
BMC MEDICINE (2012)
TWIST1 Is an ERK1/2 Effector That Promotes Invasion and Regulates MMP-1 Expression in Human Melanoma Cells
Michele B. Weiss et al.
CANCER RESEARCH (2012)
Identification and characterization of novel spliced variants of PRMT2 in breast carcinoma
Jing Zhong et al.
FEBS JOURNAL (2012)
PAK1 is a breast cancer oncogene that coordinately activates MAPK and MET signaling
Y. Shrestha et al.
ONCOGENE (2012)
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami et al.
CANCER DISCOVERY (2012)
Alternative splicings on p53, BRCA1 and PTEN genes involved in breast cancer
Naoko Okumura et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer
Charles J. David et al.
NATURE (2010)
Novel variants of muscle calpain 3 identified in human melanoma cells: cisplatin-induced changes in vitro and differential expression in melanocytic lesions
D. Moretti et al.
CARCINOGENESIS (2009)
Alternative Splicing in Lung Cancer
Ruben Pio et al.
JOURNAL OF THORACIC ONCOLOGY (2009)
Jmjd6 Catalyses Lysyl-Hydroxylation of U2AF65, a Protein Associated with RNA Splicing
Celia J. Webby et al.
SCIENCE (2009)
Oncogenic BRAF Regulates Melanoma Proliferation through the Lineage Specific Factor MITF
Claudia Wellbrock et al.
PLOS ONE (2008)
JMJD6 is a histone arginine demethylase
Bingsheng Chang et al.
SCIENCE (2007)
Identification of alternatively spliced TIMP-1 mRNA in cancer cell lines and colon cancer tissue
P. A. Usher et al.
MOLECULAR ONCOLOGY (2007)
Regulation of MAPKs by growth factors and receptor tyrosine kinases
Menachem Katz et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2007)
Defective fetal liver erythropoiesis and T lymphopoiesis in mice lacking the phosphatidylserine receptor
Y Kunisaki et al.
BLOOD (2004)
Inhibition of growth and invasive ability of melanoma by inactivation of mutated BRAF with lentivirus-mediated RNA interference
H Sumimoto et al.
ONCOGENE (2004)
Phosphatidylserine receptor is required for clearance of apoptotic cells
MO Li et al.
SCIENCE (2003)
PAKI phosphorylation of MEK1 regulates fibronectin-stimulated MAPK activation
JK Slack-Davis et al.
JOURNAL OF CELL BIOLOGY (2003)
Phosphorylation of Raf-1 by p21-activated kinase 1 and Src regulates Raf-1 autoinhibition
NH Tran et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Mutations of the BRAF gene in human cancer
H Davies et al.
NATURE (2002)
Interaction between active Pak1 and Raf-1 is necessary for phosphorylation and activation of Raf-1
MW Zang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
A receptor for phosphatidylserine-specific clearance of apoptotic cells
VA Fadok et al.
NATURE (2000)
Cell cycle-dependent variations in c-Jun and JunB phosphorylation: a role in the control of cyclin D1 expression
L Bakiri et al.
EMBO JOURNAL (2000)